UPCARE
Live / Registered — Registered (as of 22 Feb 2022)
What this means for you
Registered since 22 Feb 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79298532
- Registration number
- 6648773
- Mark type
- Design + words
- Filed
- 21 Oct 2020
- Published for opposition
- 07 Dec 2021
- Registered
- 22 Feb 2022
- Attorney of record
- Katherine P. Califa
Goods and services
- Class 005 — Pharmaceuticals: Acne treatment preparations in the form of cleansers; anti-bacterial pharmaceutical preparations; Capsules sold empty for pharmaceutical purposes; effervescent analgesic pharmaceutical preparations; Extracts of plants in capsule form for pharmaceutical purposes; Throat lozenges for pharmaceutical purposes; pharmaceutical compound eye-drops; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical preparations containing vitamins for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical preparations for animals for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical preparations for health care for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical preparations for human use for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical preparations for nasal use for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical preparations for oral use for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical preparations for personal use for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment of acne; Pharmaceutical preparations for veterinary use for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical preparations in the form of emulsions for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical preparations in the form of throat lozenges; Pharmaceutical preparations in the form of tablets for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical products for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical products derived from natural sources for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical products for use by humans for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical products in gel form for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; Pharmaceutical tablets for anti-aging, for the treatment and prevention of respiratory illnesses, diabetes, neuro-degeneration, and central nervous system disorders, and for the maintenance, support, and improvement of brain health; plant extracts for pharmaceutical use; Drug delivery agents in the form of tablets that facilitate the delivery of pharmaceutical preparations; medicated mouth spray; mouth sprays for medical use; medicated throat sprays; medicated mouthwashes; medical mouthwashes; mouthwashes and gargles for medical purposes; dietary supplements; dietary supplements for animals; herbal dietary supplements; vitamin supplements; vitamin supplements for animals; Nutritionally fortified herbal beverages for medicinal use; medical toothpastes; medicated toothpaste; eye drops; dietary supplements with a cosmetic effect
Owner
Prosecution history
- 16 Aug 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 27 Jul 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 27 Jul 2022 — FINAL DISPOSITION PROCESSED
- 22 May 2022 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 22 Feb 2022 — REGISTERED-PRINCIPAL REGISTER
- 07 Dec 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Dec 2021 — PUBLISHED FOR OPPOSITION
- 06 Dec 2021 — NOTIFICATION PROCESSED BY IB
- 17 Nov 2021 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 17 Nov 2021 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 17 Nov 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Nov 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Oct 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Oct 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Oct 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED